Skip to main content

Arthur Daemmrich, PhD

Arthur Daemmrich, Ph.D.
Volunteer Associate Professor, Department of History and Philosophy of Medicine

2025 Robinson
MS 1025, KUMC
3901 Rainbow Blvd., Kansas City, KS 66160
(913) 588-7040 -- office
(913) 588-7060 -- fax

Education and Training

  •  University of Pennsylvania, B.A. in History and Sociology of Science
  •  Cornell University, Ph.D. in Science and Technology Studies 

Research, Teaching and Service

My research explores relationships between regulation and innovation through historical and comparative studies of the pharmaceutical industry, the chemicals sector, and healthcare systems. I am the author of Pharmacopolitics: Drug Regulation in the United States and Germany and have published over 25 peer-reviewed journal articles and book chapters in science and technology studies; the history of science, technology and medicine; and health and business policy, as well as numerous teaching cases and notes. In addition to my affiliation with the University of Kansas School of Medicine, I am the director of the Lemelson Center for the Study of Invention and Innovation at the Smithsonian Institution, Prior to joining the KU Med faculty in 2013, I was an assistant professor at Harvard Business School, and a visiting professor at the China Europe International Business School.

Selected Publications

A. Daemmrich, "Pharmaceutical Manufacturing in America: A Brief History," Pharmacy in History 59 (2017), 63-72.

A. Daemmrich, "Invention, Innovations Systems, and the Fourth Industrial Revolution," Technology and Innovation 18 (2017), 257-265. 

A. Daemmrich, "Wichita County Health Center: Strategic Planning," Ivey Publishing case 8B16M084 (May 2016); and accompanying teaching note: "Wichita County Health Center: Strategic Planning (TN), Ivey Publishing teaching note 8B16M084 (May 2016).

A. Daemmrich, "Using the SWOT Framework in the Health Care Sector," Ivey Publishing note 9B16M076 (May 2016).

A. Daemmrich, "Children's Hospital Oakland: End-of-Life Dilemmas," Ivey Publishing case 9B16C007 (March 2016); and accompanying teaching note: "Children's Hospital Oakland: End-of-Life Dilemmas (TN)," Ivey Publishing teaching note 8B16C007 (March 2016).

A. Daemmrich, "Healthcare Reform in the United States and China: Pharmaceutical Market Implications," Journal of Pharmaceutical Policy and Practice 7 (2014), 9. doi:10.1186/2052-3211-7-9

Presentations and Exhibits

A. Daemmrich, "What about the Children? Chemical Testing Programs in the United States and European Union," Society for the History of Technology, Philadelphia, 26-29 October 2017.

A. Daemmrich, "Crossing Boundaries: Innovation in Theory and in Practice," Westminster University, London, 6 April 2016.

A. Daemmrich, "Vulnerable Subjects, Vulnerable Knowledge: Children's Chemical Testing Programs in the United States and European Union," University of Minnesota, History of Science, Technology and Medicine Colloquium, 5 December 2014.

Last modified: Jul 16, 2019